Catalyst Wire Dossier Catalyst Wire Dossier

Insulin 287

NNC0148-0287 C · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Insulin 287, covering 2021-01-08 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together [Phase 1]

See pricing